Yan Song
About
Yan Song is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology.
According to data from OpenAlex, Yan Song has authored 132 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pulmonary and Respiratory Medicine, 36 papers in Oncology and 24 papers in Epidemiology. Recurrent topics in Yan Song's work include Renal cell carcinoma treatment (14 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and Gastric Cancer Management and Outcomes (9 papers). Yan Song is often cited by papers focused on Renal cell carcinoma treatment (14 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and Gastric Cancer Management and Outcomes (9 papers). Yan Song collaborates with scholars based in United States, China and United Kingdom. Yan Song's co-authors include Howard C. Crawford, M. Kay Washington, James Signorovitch, Namita Tundia, Jinwan Wang, Keith A. Betts, Vibeke Strand, Arijit Ganguli, Hongbo Yang and Yuxian Bai and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and SHILAP Revista de lepidopterología.
In The Last Decade
Yan Song
108 papers receiving 1.4k citations
Peers
Yan Song
Scott Ernst Canada
Abdurrahman Işıkdoğan Türkiye
Thorsten Fuereder Austria
Jaya Ghosh India
Iuliana Shapira United States
Akmal Safwat Denmark
Ta‐Chung Chao Taiwan
Philip P. Breitfeld United States
Victoria M. Chia United States
Margherita Nannini Italy
Citations per year, relative to Yan Song Yan Song (= 1×)
peers
Scott Ernst
Countries citing papers authored by Yan Song
Since
Specialization
Citations
This map shows the geographic impact of Yan Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Song more than expected).
Fields of papers citing papers by Yan Song
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Yan Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Song. The network helps show where Yan Song may publish in the future.
Co-authorship network of co-authors of Yan Song
This figure shows the co-authorship network connecting the top 25 collaborators of Yan Song. A scholar is included among the top collaborators of Yan Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Song. Yan Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Eiden, Amanda L, Qing Liu, Yan Song, et al.. (2025). Temporal trends in vaccination and antibiotic use among young children in the United States, 2000–2019. Antimicrobial Stewardship & Healthcare Epidemiology. 5(1). e151–e151.
2.
Jonasch, Eric, Yan Song, Richard Berman, et al.. (2024). Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United States. Orphanet Journal of Rare Diseases. 19(1). 73–73.
3.
Mohanty, Salini, Nicolae Done, Qing Liu, et al.. (2024). Incidence of pneumococcal disease in children ≤48 months old in the United States: 1998–2019. Vaccine. 42(11). 2758–2769.
4.
Prabhu, Vimalanand S., et al.. (2024). Real-world perioperative treatment patterns and burden of recurrent disease in patients with high-risk endometrial cancer: a SEER-Medicare study. Journal of Medical Economics. 27(1). 1410–1420.
5.
Donington, Jessica, Xiaohan Hu, Su Zhang, et al.. (2024). Real-World Neoadjuvant Treatment Patterns and Outcomes in Resected Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 25(5). 440–448.
6.
Zhao, Weiwei, Juan Liu, Liyan Chen, et al.. (2024). Efficacy and Safety of Carfilzomib-Based Regiments for the Treatment of Relapsed or Refractory Multiple Myeloma: Single-Center Real-Word Data. Blood. 144(Supplement 1). 7024–7024.
7.
Donington, Jessica, Xiaohan Hu, Su Zhang, et al.. (2023). Event-free survival as a predictor of overall survival and recurrence burden of patients with non–small cell lung cancer receiving neoadjuvant therapy. Journal of Thoracic and Cardiovascular Surgery. 168(4). 1261–1269.e1.
8.
Hu, Tianyan, Eric Sarpong, Yan Song, et al.. (2023). Incidence of non-invasive all-cause pneumonia in children in the United States before and after the introduction of pneumococcal conjugate vaccines: a retrospective claims database analysis. SHILAP Revista de lepidopterología. 15(1). 8–8.
9.
Lin, Chenyu, Gautam Sajeev, Patrick J. Stiff, et al.. (2022). Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood. Transplantation and Cellular Therapy. 29(1). 52.e1–52.e9.
10.
Song, Yan, et al.. (2022). EE371 Disease Management Costs for Patients With Intermediate-High or High-Risk Renal Cell Carcinoma (RCC) Following Nephrectomy. Value in Health. 25(12). S128–S128.
11.
Bergman, Martin, Namita Tundia, Naomi Martin, et al.. (2022). Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial. Arthritis Research & Therapy. 24(1). 155–155.
12.
Bensimon, Arielle G., Zheng‐Yi Zhou, Yan Song, et al.. (2020). An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA. Clinical Drug Investigation. 40(7). 629–643.
13.
Bensimon, Arielle G., Zheng‐Yi Zhou, Yan Song, et al.. (2019). Cost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United States. Journal of Medical Economics. 22(10). 981–993.
14.
Griffin, James D., et al.. (2019). PCN168 ECONOMIC BURDEN OF RELAPSE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): A RETROSPECTIVE CLAIMS-BASED ANALYSIS. Value in Health. 22. S468–S468.
15.
Schultz, Neil M., David F. Penson, Samuel Wilson, et al.. (2019). Adverse Events Associated with Cumulative Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims Analysis. Drug Safety. 43(1). 23–33.
16.
Strand, Vibeke, Namita Tundia, Yan Song, Dendy Macaulay, & Mahesh Fuldeore. (2018). Economic Burden of Patients with Inadequate Response to Targeted Immunomodulators for Rheumatoid Arthritis. Journal of Managed Care & Specialty Pharmacy. 24(4). 344–352.
17.
Sun, Guibo, S.L. Wang, Yan Song, et al.. (2017). Hypofractionated Radiation Therapy After Mastectomy for the Treatment of High-Risk Breast Cancer: 5-Year Follow-Up Result of a Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 99(2). S3–S4.
18.
Husni, M. Elaine, Keith A. Betts, Jenny Griffith, Yan Song, & Arijit Ganguli. (2017). Benefit-risk trade-offs for treatment decisions in moderate-to-severe rheumatoid arthritis: focus on the patient perspective. Rheumatology International. 37(9). 1423–1434.
19.
Song, Yan, M. Kay Washington, & Howard C. Crawford. (2010). Loss of FOXA1/2 Is Essential for the Epithelial-to-Mesenchymal Transition in Pancreatic Cancer. Cancer Research. 70(5). 2115–2125.
20.
Song, Yan, et al.. (2010). Relationship between HER2/neu gene amplification and protein expression and prognosis in patients with advanced gastric carcinoma. Chinese Journal of Cancer. 29(1). 71–75.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Scott Ernst Breakdown of academic impact, for papers by Abdurrahman Işıkdoğan Breakdown of academic impact, for papers by Thorsten Fuereder Breakdown of academic impact, for papers by Jaya Ghosh Breakdown of academic impact, for papers by Iuliana Shapira Breakdown of academic impact, for papers by Akmal Safwat Breakdown of academic impact, for papers by Ta‐Chung Chao Breakdown of academic impact, for papers by Philip P. Breitfeld Breakdown of academic impact, for papers by Victoria M. Chia Breakdown of academic impact, for papers by Margherita Nannini